Results 191 to 199 of about 4,511 (199)

ANTI-CD44V6 ANTIBODIES AND THEIR USE TO TREAT CD44V6 OVEREXPRESSING CANCERS

NESTOR MARIKA, PERSSON LOTSHOLM HELENA, HOFSTRÖM CAMILLA, WALLE MARIA, OHLIN MATS   +4 more
openaire   +1 more source

Peptides for binding to CD44v6 and use thereof

2021
LEE BYUNG-HEON, KHAN FATIMA
openaire   +1 more source

CD44V6-DERIVED PEGYLATED PEPTIDES

2014
ORIAN-ROUSSEAU VÉRONIQUE, MATZKE ALEXANDRA, LEVKIN PAVEL, SCHMITT MARK, LI LINXIAN, PARVESH WADHWANI   +5 more
openaire   +1 more source

CD44V6-Derived Peptides for Treating Breast Cancer

2016
ORIAN-ROUSSEAU VERONIQUE, MATZKE ALEXANDRA, PONTA HELMUT   +2 more
openaire   +2 more sources

Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis

Tumor Biology, 2014
exaly  

Evaluation of CD44v6 targeting strategies in HNSCC.

2019
Osterode, E., Schoetz, U., Orth, M., Selmansberger, M., Schuster, J., Hess J., Unger, K., Zitzelsberger, H., Belka, C., Lauber, K.   +9 more
openaire   +1 more source

MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6

1995
ADOLF GUENTHER R, PATZELT ERIK
openaire   +2 more sources

PEPTIDES BINDING TO CD44V6 AND USE THEREOF

2019
LEE BYUNG-HEON, KHAN FATIMA
openaire   +2 more sources

Expression of CD44v6 in Melanocytic Lesions and Influence of the hepatocyte growth factor on the expression of CD44v6 in Melanocytes and Melanoma cell lines

2008
Damm, S., Koefinger, P., Stefan, M., Wels, C., Mebes, G., Kerl, H., Otte, M., Schaider, H.   +7 more
openaire   +1 more source